LV11727A - Farmaceitiska kompozicija - Google Patents

Farmaceitiska kompozicija

Info

Publication number
LV11727A
LV11727A LV950255A LV950255A LV11727A LV 11727 A LV11727 A LV 11727A LV 950255 A LV950255 A LV 950255A LV 950255 A LV950255 A LV 950255A LV 11727 A LV11727 A LV 11727A
Authority
LV
Latvia
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
LV950255A
Other languages
English (en)
Other versions
LV11727B (en
Inventor
Ivars Kalvins
Maris Veveris
Original Assignee
Ivars Kalvins
Maris Veveris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivars Kalvins, Maris Veveris filed Critical Ivars Kalvins
Priority to LV950255A priority Critical patent/LV11727B/lv
Priority to PCT/LV1996/000003 priority patent/WO1997006795A1/en
Publication of LV11727A publication Critical patent/LV11727A/lv
Publication of LV11727B publication Critical patent/LV11727B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
LV950255A 1995-08-21 1995-08-21 Pharmaceutical composition LV11727B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
LV950255A LV11727B (en) 1995-08-21 1995-08-21 Pharmaceutical composition
PCT/LV1996/000003 WO1997006795A1 (en) 1995-08-21 1996-08-20 Pharmaceutical compositions containing gamma-butyrobetain for treatment of blood flow disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LV950255A LV11727B (en) 1995-08-21 1995-08-21 Pharmaceutical composition

Publications (2)

Publication Number Publication Date
LV11727A true LV11727A (lv) 1997-04-20
LV11727B LV11727B (en) 1997-08-20

Family

ID=19736012

Family Applications (1)

Application Number Title Priority Date Filing Date
LV950255A LV11727B (en) 1995-08-21 1995-08-21 Pharmaceutical composition

Country Status (2)

Country Link
LV (1) LV11727B (lv)
WO (1) WO1997006795A1 (lv)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062322A2 (en) * 2001-02-05 2002-08-15 Jallal Messadek Glycine betaine and its use as anti-hemorrhagic agent
BE1012495A3 (fr) * 1999-03-02 2000-11-07 Messadek Jallal La glycine-betaine pour son usage antithrombotique.
US7608640B2 (en) 1999-03-02 2009-10-27 Jallal Messadek Glycine betaine and its use
LV12979B (en) * 2001-09-07 2003-05-20 Ivars Kalvins Pharmaceutical composition
BE1015608A6 (fr) 2003-07-15 2005-06-07 Messadek Jallal Traitement des arterites.
US20060233877A1 (en) * 2002-11-25 2006-10-19 Jallal Messadek Betaine compositions
NZ545032A (en) * 2003-07-28 2009-02-28 Smithkline Beecham Corp Cycloalkylidene compounds as modulators of estrogen receptor
EP1667960B1 (en) 2003-08-04 2008-02-13 "Joint Stock Company Grindeks" Meldonium salts, method of their preparation and pharmaceutical composition on their basis
WO2006050581A2 (en) 2004-11-10 2006-05-18 Jallal Messadek Betaine as agent against arthropod - or mosquito -borne diseases
WO2006086856A1 (en) 2005-02-15 2006-08-24 Messadek, Jallal Combination therapeutic compositions and method of use
CN101180073A (zh) 2005-04-27 2008-05-14 贾拉尔·梅萨德克 胰岛素组合
RS55092B1 (sr) * 2011-04-27 2016-12-30 Grindeks Jsc Upotreba 3-karboksi-n-etil-n,n-dimetilpropan-1-aminijum soli u lečenju kardiovaskularne bolesti

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1198434B (it) * 1981-01-06 1988-12-21 Sigma Tau Ind Farmaceuti Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
IT1210935B (it) * 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1157238B (it) * 1982-10-29 1987-02-11 Sigma Tau Ind Farmaceuti Impiego di 1-carnitina per migliorare i paramenti biochimici e comportamentali dell'eta' senile
US5030458A (en) * 1989-11-27 1991-07-09 Shug Austin L Method for preventing diet-induced carnitine deficiency in domesticated dogs and cats
JPH01213259A (ja) * 1988-02-23 1989-08-28 Kyowa Hakko Kogyo Co Ltd カルニチンおよびカルニチンアミドの精製法

Also Published As

Publication number Publication date
LV11727B (en) 1997-08-20
WO1997006795A1 (en) 1997-02-27

Similar Documents

Publication Publication Date Title
NO962606L (no) Farmasöytisk sammensetning
IS4706A (is) Lyfjasamsetningar
CY2005007I2 (el) Φαρμακευτικες συνθεσεις που περιεχουν δαριφενακινη
FI944832A (fi) Farmaseuttinen koostumus
NO981008D0 (no) Farmasöytisk formulering
BR9607058A (pt) Composição
BR9606809A (pt) Composição inseticidamente ativa
BR9610214A (pt) Compostos farmacéuticos
ITMI932540A0 (it) Composizione farmaceutica
LV11727A (lv) Farmaceitiska kompozicija
DE69614407T2 (de) Pharmazeutische zusammensetzungen
FI973229A (fi) Uusi farmaseuttinen koostumus
BR9507768A (pt) Composição farmacêutica
ID18698A (id) Komposisi farmasi
FI973280A (fi) Farmaseuttinen koostumus
ITMI942166A0 (it) Composizioni farmaceutiche miorilassanti
FI973230A (fi) Uusi farmaseuttinen formulaatio
LV10579A (lv) Farmaceitiska kompozicija
BR9607946A (pt) Composição
BR9605777A (pt) Composição farmacêutica
NO965448D0 (no) Farmasöytiske forbindelser
ITMI962628A0 (it) Composizione farmaceutica
FI962738A0 (fi) Farmaseuttiset koostumukset
BR9605131A (pt) Composição farmacêutica
IT1272935B (it) Composizione farmaceutica contenente n-acetil-cisteina